A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...

New Delhi, Nov 19 (UNI) India has announced its first indigenous CRISPR-based gene therapy for sickle cell disease, a severe hereditary blood disorder that disproportionately affects tribal ...

Learn more about whether Aurinia Pharmaceuticals Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ ...

As tech titans back startups looking to create genetically modified babies, Claudia Cockerell asks: is it about stopping disease, or something darker?

In a new study publishing November 19 in the Cell Press journal Trends in Biotechnology, researchers used a gene-editing technology called CRISPR to ...

Hosts David and Gina explore how scientists over the centuries unlocked the ability to edit our genes ...

USA News Group News Commentary ? The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies race to commercialize therapies that read, replace, and rewrite cellular ...

ToolGen (KOSDAQ: 199800; CEO Jong-sang Ryu), a leader in genome editing technology, announced that the United States Patent ...

“With the development and transfer of India’s first indigenous CRISPR-based gene therapy, the nation has taken a major step toward fulfilling Prime Minister Narendra Modi’s vision of a Sickle ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Chronic diseases once meant a lifetime of management. But a new generation of cell and gene therapies is challenging that paradigm. Markets are responding. The global cell and gene therapy market is ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...